Results for tag: "Pelizaeus Merzbacher Disease Drug"

Pelizaeus Merzbacher Disease (PMD) is a rare, inherited neurological disorder that affects the central nervous system. It is characterized by progressive deterioration of motor skills, cognitive abilities, and speech. Treatment for PMD is limited to supportive care, and there is currently no cure. The PMD drug market is a small but growing segment of the larger Central Nervous System (CNS) drug market. It is composed of pharmaceutical companies that are researching and developing treatments for PMD. These companies are focused on developing therapies that can slow or stop the progression of the disease, as well as improve the quality of life for those affected. The PMD drug market is still in its early stages, but there is potential for growth as more treatments are developed. Companies in this market include Biogen, Novartis, and Sanofi, among others. Show Less Read more